Cholangiocarcinoma: Era of Immune Check-Point Inhibitors

被引:0
|
作者
El Hag, Mohamed I. [1 ]
Wood-Trageser, Michelle [2 ]
Patel, Krishna [2 ]
Specht, Susan [2 ]
Sasatomi, Eizaburo [3 ]
Sun, Weijing [4 ]
Demetris, Anthony [5 ]
机构
[1] Univ Pittsburgh, Med Ctr, Presbyterian Shadyside, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[3] Dept Pathol & Lab Med, Chapel Hill, NC USA
[4] Kansas Univ, Med Ctr, Lawrence, KS USA
[5] UPMC Montefiore, Pittsburgh, PA USA
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
1750
引用
收藏
页码:633 / 633
页数:1
相关论文
共 50 条
  • [41] Immune Check-Point Blockade as a Potential Therapeutic Strategy for Undifferentiated Malignancies
    Devereaux, Kelly
    Charville, Gregory
    Zhao, Shuchun
    Cherry, Athena
    van de Rijn, Matt
    Natkunam, Yasodha
    [J]. MODERN PATHOLOGY, 2017, 30 : 456A - 456A
  • [42] The immunocytokine L19-TNF eradicates sarcomas in combination with chemotherapy agents or with immune check-point inhibitors
    Corbellari, Riccardo
    Nadal, Lisa
    Villa, Alessandra
    Neri, Dario
    De Luca, Roberto
    [J]. ANTI-CANCER DRUGS, 2020, 31 (08) : 799 - 805
  • [43] Releasing the brake: safety profile of immune check-point inhibitors in non-small cell lung cancer
    Genova, Carlo
    Rossi, Giovanni
    Rijavec, Erika
    Biello, Federica
    Barletta, Giulia
    Tagliamento, Marco
    Grossi, Francesco
    [J]. EXPERT OPINION ON DRUG SAFETY, 2017, 16 (05) : 573 - 585
  • [44] Integrin inactivation as a mitotic check-point
    Lerche, M.
    Waterman, C. M.
    Thiam, H. R.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2023, 34 (02) : 316 - 316
  • [45] T-reg transcriptomic signatures identify response to check-point inhibitors
    Noblejas-Lopez, Maria del Mar
    Garcia-Gil, Elena
    Perez-Segura, Pedro
    Pandiella, Atanasio
    Gyorffy, Balazs
    Ocana, Alberto
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01):
  • [46] The interplay of obesity, gut microbiome and diet in the immune check point inhibitors therapy era
    Spyrou, Nikolaos
    Vallianou, Natalia
    Kadillari, Jona
    Dalamaga, Maria
    [J]. SEMINARS IN CANCER BIOLOGY, 2021, 73 : 356 - 376
  • [47] Morphological spectrum of immune check-point inhibitor therapy-associated gastritis
    Johncilla, Melanie
    Grover, Shilpa
    Zhang, Xuchen
    Jain, Dhanpat
    Srivastava, Amitabh
    [J]. HISTOPATHOLOGY, 2020, 76 (04) : 531 - 539
  • [48] Neurological toxicity in cancer patients treated with immune check-point inhibitor therapy
    Reoma, Lauren
    Narayan, Ram
    Albert, Julie
    Gudlavalleti, Aashrai
    Smith, Bryan
    Schindler, Matthew
    Reich, Daniel
    Apolo, Andrea
    Karzai, Fatima
    Rajan, Arun
    Gulley, James
    Khan, Omar
    Nath, Avindra
    [J]. NEUROLOGY, 2019, 92 (15)
  • [49] Neurologic Immune-related Adverse Events Associated with Check-point Inhibitors: A Case Study and Systematic Review of the Literature
    Juster-Switlyk, Kelsey
    Johnson, Nicholas
    [J]. NEUROLOGY, 2018, 90
  • [50] Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors
    Sue, Masahiko
    Takeuchi, Yasuto
    Hirata, Shoichiro
    Takaki, Akinobu
    Otsuka, Motoyuki
    [J]. CANCERS, 2024, 16 (10)